Page last updated: 2024-08-21

thiazolidines and Myeloproliferative Disorders

thiazolidines has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Griner, LN; Huszar, D; Lambert, QT; Mazzacurati, L; Pradhan, A; Reuther, GW	1

Other Studies

1 other study(ies) available for thiazolidines and Myeloproliferative Disorders

Article	Year
The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells. Oncotarget, 2015, Nov-24, Volume: 6, Issue:37 Topics: Apoptosis; bcl-Associated Death Protein; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Synergism; Humans; Imidazoles; Immunoblotting; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyrazoles; Pyridazines; Pyrimidines; Signal Transduction; Thiazolidines; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay	2015

Article

Year

The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells.

Oncotarget, 2015, Nov-24, Volume: 6, Issue:37

Topics: Apoptosis; bcl-Associated Death Protein; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Synergism; Humans; Imidazoles; Immunoblotting; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyrazoles; Pyridazines; Pyrimidines; Signal Transduction; Thiazolidines; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay

2015